RxSight, Inc.
RXST- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001111485
In the last 90 days, RxSight, Inc. insiders filed 0 open-market purchases and 4 sales; 151 institutions reported holding it in 13F filings for Q2 2026, worth $199.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding RxSight, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 49 | 53 | +4 |
| Shares | 9.31M | 9.11M | −195.6K (−2.1%) |
| Value | $131.0M | $109.3M | −$21.7M (−16.6%) |
New holders (8)
Institutions that held RxSight, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 237,641 | $2.85M | 0.01% |
| Dimensional Fund Advisors LP | 16,115 | $193.0K | 0.00% |
| Boston Private Wealth LLC | 11,015 | $132.0K | 0.00% |
| HighTower Advisors, LLC | 10,015 | $120.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 6,526 | $78.3K | 0.00% |
| Cubist Systematic Strategies, LLC | 5,711 | $69.0K | 0.00% |
| Acadian Asset Management LLC | 1,611 | $19.0K | 0.00% |
| UBS Group AG | 1,049 | $13.0K | 0.00% |
Sold out (4)
Institutions that held RxSight, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| EAM Investors, LLC | 176,270 | $2.48M |
| RTW Investments, LP | 150,000 | $2.11M |
| EAM Global Investors LLC | 99,317 | $1.40M |
| Alliancebernstein L.P. | 17,194 | $242.0K |